Autres langues NextCure, Inc.

Actions

NXTC

US65343E2072

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 28/09/2026			Varia. 5j.	Varia. 1 janv.
5,080 ^USD	0,00%		-6,96%	-64,20%

03/09	NextCure conclut un neuvième avenant à son contrat de bail et libère ses locaux au 8000 Virginia Manor Road	CI
12/08	Avere, filiale de RTW Biotech, s'introduit en bourse aux États-Unis via une fusion inversée avec NextCure	AN

Autres langues

03/09	NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road
12/08	RTW Biotech's Avere to go public in US in reverse merger with NextCure
12/08	RTW Biotech to Inject $6 Million in Avere Therapeutics Ahead of Reverse Merger
11/08	Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001
10/08	Xcellon Biologics LLC entered into agreement to acquire GMP biologics manufacturing facility from NextCure, Inc..
06/08	NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results
06/08	NextCure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
15/07	Top Premarket Decliners
15/07	Power Moves: NXTC, TOON, SHPH, COCH Entry Points Ignite on Major Catalysts
15/07	Kartoon Studios (NYSE: TOON) Enters Catalyst-Rich Growth Phase
14/07	Top Midday Gainers
14/07	NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders
14/07	Avery Therapeutics, Inc. entered into a definitive merger agreement to acquire NextCure, Inc. for $250 million in a reverse merger transaction.
14/07	Top Premarket Gainers
14/07	NextCure to Merge With Avere Therapeutics in All-Stock Deal
14/07	NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
29/06	NextCure, Inc.(NasdaqGS:NXTC) added to Russell Microcap Value Benchmark Index
29/06	NextCure, Inc.(NasdaqGS:NXTC) added to Russell 3000E Index
29/06	NextCure, Inc.(NasdaqGS:NXTC) added to Russell Microcap Index
29/06	NextCure, Inc.(NasdaqGS:NXTC) added to Russell 3000E Value Benchmark
04/06	NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
01/06	NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026
01/06	NextCure, Inc. Presents Positive SIM0505 Phase 1 Dose Escalation Data In Patients With Gynecologic Cancers At ASCO
08/05	NextCure : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
07/05	NextCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026